Contineum Therapeutics Inc.
CTNM | NASDAQ
$13.59
+$0.04 (+0.30%)
Sep 22, 2026, 12:09 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 |
|---|---|---|---|---|---|
PE Ratio | -5.27 | -8.99 | 118.46 | -15.88 | -13.39 |
PEG Ratio | -0.16 | 0.01 | -1.04 | 1.01 | n/a |
PS Ratio | n/a | n/a | 7.74 | n/a | n/a |
PB Ratio | 1.21 | 1.91 | -5.70 | 9.86 | 6.28 |
P/FCF Ratio | -5.70 | -11.35 | 20.44 | -19.12 | -14.64 |
P/OCF Ratio | -5.72 | -11.53 | 20 | -19.23 | -14.73 |
OCF/S Ratio | n/a | n/a | 38.70 | n/a | n/a |
Debt / Equity Ratio | 0.03 | 0.03 | -2.84 | 0.15 | 0.08 |
Quick Ratio | 27.50 | 20.69 | 23.29 | 6.41 | 18.99 |
Current Ratio | 27.50 | 20.69 | 23.29 | 6.41 | 18.99 |
Asset Turnover | n/a | n/a | 0.38 | n/a | n/a |
Interest Coverage | n/a | n/a | -77.29 | -58.56 | -86.29 |
Return on Equity | -22.98% | -21.34% | -33.44% | -61.76% | -47.09% |
Return on Assets | -21.68% | -19.85% | 17.43% | -47.90% | -41.13% |
Return on Invested Capital | -25.28% | -24.91% | -12.57% | -47.19% | -42.07% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | 100% | n/a | n/a |
Net Profit Margin | n/a | n/a | 45.44% | n/a | n/a |
Pretax Profit Margin | n/a | n/a | 46.34% | n/a | n/a |
Operating Profit Margin | n/a | n/a | -32.15% | n/a | n/a |
FCF Margin | n/a | n/a | 37.87% | n/a | n/a |
EBITDA Margin | n/a | n/a | 47.15% | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove CTNM